2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)

BACKGROUND: The DOOR approach has been proposed as an improved way to evaluate novel anti-infective agents by focusing on benefits and harms and providing an assessment of the patient experience. We conducted a Phase 3 cIAI trial comparing IV ertapenem (stepped down to either oral ciprofloxacin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aronin, Steven I, Dunne, Michael W, Gupta, Jayanti, Puttagunta, Sailaja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678622/
http://dx.doi.org/10.1093/ofid/ofad500.1730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678622/
http://dx.doi.org/10.1093/ofid/ofad500.1730

Ejemplares similares